Defunct Company
Total Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
527
NCT01793064
An Adaptive Physical Activity Intervention for Overweight Adults
Phase: N/A
Role: Collaborator
Start: Jun 30, 2010
Completion: Sep 30, 2011
NCT03937869
Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
Phase: Phase 4
Role: Lead Sponsor
Start: Nov 28, 2018
Completion: Nov 5, 2020
NCT03935217
A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis
Phase: Phase 3
Start: Apr 23, 2019
Completion: Mar 25, 2020
NCT04502212
Pilot Study to Assess the Effects of Hepatic Ultrasound Insonification on Subjects With T2DM
Start: Jul 30, 2020
Completion: May 24, 2021
NCT04185064
Cryopneumatic Device After Shoulder Surgeries
Start: Sep 1, 2020
Completion: May 17, 2023
NCT04701489
UNITE Study (UMN-GE) for COVID-19
Start: Jan 14, 2021
Completion: Apr 7, 2021
NCT05360576
An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study
Phase: Phase 2
Start: Feb 24, 2022
Completion: Jul 4, 2022
NCT05360550
A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females
Start: Jul 5, 2022
Completion: Jan 12, 2023
NCT05796492
Ultrasound Treatment on Wound Healing Time
Start: Jun 22, 2023
Completion: Dec 19, 2024
NCT05390645
A Study of MFA-370 in Patients with Metastatic Urothelial Cancer
Phase: Phase 1/2
Start: Dec 1, 2024
Completion: Dec 1, 2025